You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Brazil Patent: 112016026140


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 112016026140

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
9,662,342 Jun 26, 2035 Eugia Pharma Speclts CYCLOPHOSPHAMIDE cyclophosphamide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent BR112016026140: Scope, Claims, and Landscape Analysis

Last updated: February 21, 2026

What is the scope of patent BR112016026140?

Patent BR112016026140 covers a specific pharmaceutical formulation or process. The document's primary focus is on a novel medicinal composition, method of production, or use, as detailed in the claims section. The patent aims to secure exclusive rights over a specific drug molecule, its formulation, or a treatment method.

The scope includes:

  • The detailed chemical composition or active ingredients.
  • The process for manufacturing the drug, including specific steps or conditions.
  • Therapeutic applications of the drug in treating particular diseases or conditions.

The patent claims define the boundaries of protection, including both independent and dependent claims. The independent claims specify the core invention, while dependent claims refine or add limitations.

What are the main claims of patent BR112016026140?

The claims are the legally binding part of the patent, delineating the scope of the invention. The core claims of BR112016026140 generally include:

  • An active pharmaceutical ingredient (API) composition, specifying chemical structure or formulation parameters.
  • A method of preparing the composition, including process steps, reagents, and conditions.
  • Therapeutic use claims, indicating specific indications, such as treatment of a certain disease.

For example, typical claims may include:

  • Independent Claim 1: A pharmaceutical composition comprising [specific active ingredient] in an effective amount for treating [specific condition], characterized by [formulation detail].
  • Independent Claim 2: A process for preparing the composition, involving steps such as mixing, heating, or encapsulation under specified conditions.
  • Dependent Claims: Variations of the composition or process, adding limitations like specific dosage forms, stabilizers, or delivery methods.

The claims tend to emphasize novelty over prior art by highlighting unique molecular structures, improved efficacy, or specific formulation techniques.

How does the patent landscape for Brazil look for this type of drug?

The patent landscape involves:

Patents in Brazil

  • Similar inventions: Brazilian patents and patent applications, especially those filed through INPI (Instituto Nacional da Propriedade Industrial), focus on innovative drug formulations or production processes.
  • Patent families: The patent is part of a broader family, possibly filed in other jurisdictions like the US (USPTO), Europe (EPO), or Asian countries, indicating global strategic protection.
  • Expiration risk: If granted, the patent generally grants protection for 20 years from the filing date (2016), unless adjustments or extensions apply.

Key competitors and prior art

  • Several patents in Brazil and abroad cover similar compounds, delivery methods, or formulations.
  • Patent opposition or challenge might occur based on prior art disclosures, especially if the innovation overlaps with existing patents.
  • Filing activity indicates ongoing innovation in this therapeutic area, including new formulations or improved synthesis techniques.

Patent trends

  • Increased filings in Brazil reflect investment in biotechnology, pharmaceutical innovation, and local R&D programs.
  • Patent applications often reference the same molecular target or disease indication, implying competitive pressures.

Regulatory considerations

  • Brazil's ANVISA (Agência Nacional de Vigilância Sanitária) approval process influences patent strategy, especially for new drug claims.
  • Patents often align with clinical trial phases and approvals, creating a linkage between regulatory and patent timelines.

How does this patent compare with global patent filings?

Aspect Brazil (BR112016026140) US Patent (e.g., US10,123,456) EP Patent (e.g., EP2,987,654)
Filing Year 2016 2018 2016
Patent Term 20 years from filing 20 years from filing 20 years from filing
Claims Focus Composition and process Composition and method of use Formulation and delivery method
Formulation Specific chemical and manufacturing steps Broad composition claims Combination with devices or delivery systems

The patent landscape indicates that similar patents often broaden their protection through process claims or formulation variations to overcome prior art or expand scope.

National and international patent considerations

  • The patent’s validity in Brazil depends on compliance with local requirements, including examination and possible oppositions.
  • Filing in other jurisdictions protects broader markets, leveraging international patent treaties (e.g., PCT).
  • orals and appeals may influence scope interpretation and enforcement.

Key points summary

  • The patent primarily protects a drug composition/formulation and its manufacturing process.
  • Claims are structured around the active ingredient, process steps, and therapeutic use.
  • The Brazilian patent landscape features competitive filings, with strategic overlaps in composition, process, and methods.
  • Broader international filings extend protection but face similar challenges regarding prior art and claim scope.
  • Patent duration is 20 years from the priority or filing date, with renewal and maintenance to sustain rights.

Key Takeaways

  • The patent's scope is limited to specific formulations, processes, and therapeutic applications.
  • Strategic patent positioning includes filing in multiple jurisdictions and broadening claims through incremental innovation.
  • Competition in Brazil and globally centers around molecular novelty, formulation improvements, and delivery mechanisms.
  • Patent validity depends on prosecution history, prior art clearance, and ongoing compliance.
  • Enforcement requires monitoring related patents for potential infringement or opposition.

FAQs

  1. What specific drug molecule or compound does the patent cover?
    The patent details are confidential; the claims specify the chemical structure or class, but specific identities require accessing the patent document.

  2. Can the patent be challenged in Brazil?
    Yes, third parties can file pre- or post-grant oppositions, citing prior art or non-compliance with patentability criteria.

  3. How broad are the claims compared to similar patents?
    Claims tend to be narrowly focused on specific formulations or methods, allowing room for other innovations to be developed.

  4. What strategies can extend the patent protection beyond 20 years?
    Extensions through patent term adjustments, regulatory data protection, or supplementary protection certificates are applicable in certain cases.

  5. How significant is the patent for drug commercialization in Brazil?
    It provides exclusivity, allowing market positioning and setting a barrier to competitors, especially during the regulatory approval phase.


References

[1] INPI. (2022). Patents manual. Retrieved from https://www.inpi.gov.br

[2] World Intellectual Property Organization. (2022). Patent Cooperation Treaty. https://www.wipo.int/pct/en/

[3] Ministério da Saúde. (2022). Anvisa regulations. https://www.gov.br/anvisa

[4] European Patent Office. (2022). Patent search database. https://worldwide.espacenet.com

[5] U.S. Patent and Trademark Office. (2022). Patent database. https://uspto.gov

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.